SeaKing Solace Releases Six Scientific White Papers and Launches New Scientific Website

SeaKing Solace has released a six-part scientific white paper series designed to establish the published scientific foundation and evidentiary boundaries for its proposed Phase 1 SAIL study. The series is now available through the organization's new online Science section, which brings the papers together with an accessible account of the hypothesis, measurement framework, and staged research strategy.

The series does not present SeaKing Solace as an established therapy, and it does not claim that the program's central hypothesis has been proven. Instead, the papers examine the scientific chain required to justify the next experiment: how natural motion is received by the vestibular system, how vestibular input may interact with autonomic physiology, how those responses should be measured and interpreted, what prior motion-rich human studies can and cannot establish, and what evidence would be needed before later controlled or clinical research could be considered.

Taken together, the reviews identify a specific unresolved question. The missing issue is not whether motion exists, whether the vestibular system detects it, or whether vestibular stimulation can affect human physiology in principle. The question is whether quantified natural multidimensional motion contains reproducible physiological structure that can be measured directly in humans and later reproduced under controlled conditions.

That distinction shapes the proposed Phase 1 research program. Rather than beginning with a predetermined therapeutic waveform, SAIL is intended to characterize the motion participants actually receive and align those measurements with synchronized physiological signals. The aim is to determine whether candidate motion-response relationships can be identified with enough precision and within-person reproducibility to warrant a subsequent controlled experiment.

A positive Phase 1 finding would not establish therapeutic efficacy or clinical benefit. It would identify candidate stimulus-response relationships worthy of controlled reproduction and further testing. Non-supportive, inconsistent, or heterogeneous findings would also be scientifically valuable: they could narrow the hypothesis, reveal important sources of individual variation, redirect measurement priorities, or show that progression is not justified in its current form.

All six documents are Scientific White Papers developed from the published scientific literature. They are not represented as peer-reviewed journal publications. Their role is to make the program's reasoning, evidence boundaries, open questions, and decision points available for scrutiny by scientists, clinicians, universities, funders, and prospective collaborators.

Publishing the reviews together also creates a common reference point for program development. Prospective research partners can examine the measurement logic before considering a collaboration; funders can see which questions an initial study can responsibly answer; and technical teams can trace proposed instrumentation decisions back to explicit scientific requirements. The series is intended to support informed evaluation, not to replace independent review or the institutional processes required for human research.

The new website will serve as the public home for that scientific series as well as information about the research program, scientific collaboration, sponsorship, and philanthropy. As program development continues, SeaKing Solace intends to use the site to distinguish clearly between what the literature establishes, what the program hypothesizes, what a future study is designed to test, and what remains unknown.